期刊文献+

基于全景视图的肺癌化疗药物剂量控制的模型设计与建设 被引量:1

Set Up of Panoramic View Dose Control Model for Chemotherapy of Lung CancerPatients
下载PDF
导出
摘要 目的为肺癌患者化疗提供个性化的化疗药物剂量控制模型,做到精准化疗。方法利用本院医疗数据平台筛选出2010-2020年的肺癌化疗患者数据,并进行分析总结。结果根据临床转归情况,归纳出化疗药物剂量、患者个体差异(性别、年龄、身高、体重等)配置相关的logistic模型,结合全景视图建立肺癌化疗药物剂量控制模型,将模型内置在医生工作站界面药物医嘱功能模块中。医生开具化疗药物医嘱时,系统根据患者基本信息,自动给出药物剂量。结论全景视图的肺癌药物剂量控制模型,可使化疗药物剂量在不同患者间实现个性化,剂量精准,同时可减少医生手工计算工作,减轻医生工作负担。 Objective To provide personalized dose control model for chemotherapy of lung cancer patients and achieve precision chemotherapy.Methods Data of lung cancer patients undergoing chemotherapy were selected and analyzed.Results Induce chemotherapy doses and differences in individual patients(gender,age,height,weight,etc.)according to the clinical outcome to configure related logistic model.Combined with panoramic views,a lung cancer chemotherapy drug dose control model was established,and built in the doctor workstation interface with the module of doctor's drug.When doctors prescribed chemotherapy drugs,the system automatically gave the drug dosage according to the basic information of patients.Conclusion The lung cancer drug dose control model with panoramic view can personalize chemotherapy drug dose among different patients,achieving dosage accuracy,and can reduce the manual calculation of doctors to reduce the burden.
作者 温晓明 段浏华 李丽红 李子奇 刘庆相 WEN Xiaoming;DUAN Liuhua;LI Lihong(Jiangxi Cancer Hospital,Nanchang University Affiliated Cancer Hospital,Nanchang,330029)
机构地区 江西省肿瘤医院
出处 《实用癌症杂志》 2021年第7期1132-1135,共4页 The Practical Journal of Cancer
关键词 全景视图 肺癌 化疗药物 控制模型 Panoramic view Lung cancer Chemotherapy dose Control model
  • 相关文献

参考文献6

二级参考文献55

  • 1刘芳,江泽飞,宋三泰,刘晓晴,王涛,闫敏,张少华,郝春芳,孙君重,申戈.单药紫杉醇治疗晚期乳腺癌剂量强度与疗效和毒性的关系[J].中华肿瘤杂志,2005,27(1):56-58. 被引量:36
  • 2周国华,曹东,郭海宜,胡夕春.黄芪注射液预防多柔比星相关性心脏毒性反应的临床观察[J].中国癌症杂志,2005,15(3):294-296. 被引量:6
  • 3王梅芳.黄芪及其制剂的作用机制与临床应用[J].中医药导报,2006,12(1):83-84. 被引量:35
  • 4郭代红.医院普通药师在合理用药工作中的作用[J].中国全科医学,2006,9(3):236-237. 被引量:6
  • 5[7]戴丹.教学药历:播下一颗种子[N].医药经济报,2007-4-5(D05).
  • 6周际昌 王奇璐.抗肿瘤药物的疗效评价[A].周际昌主编.实用肿瘤内科学[C].北京:人民卫生出版社,2003.45-47.
  • 7Limentani SA,Brufsky AM,Erban JK,et al.Phase II study of neoadjuvant docetaxel/ vinorelbine followed by surgery and adjuvant doxorubicin/cyclophosphamide in women with stage II/III breast cancer[J].Clin Breast Cancer,2006,6(6):511.
  • 8Abu-Khalaf MM,Windsor S,Ebisu K,et al.Five-year update of an expanded phase II study of dose-dense and intense doxorubicin,paclitaxeland cyclophosphamide (ATC) in high-risk breast cancer[J].Oncology,2005,69(5):372.
  • 9HendersonI C,Berry DA,Dmetri Gd,et,al.Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regiment for patients with node-positive primary breast cancer[J].J Clin Oncol,2003,21:963.
  • 10Bonneterre J,Roche H,Kerbrat P,et al.Epirubicin increase longterm survival in adjuvant chemotherapy of patients with poorprognosis,node-positive,early breast cancer:10-year follow-up results of the French Adjuvant study Group of Randomized Trial[J].J Clin Oncol,2005,23:2686.

共引文献39

同被引文献25

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部